Toulouse, France

Eric Oswald


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eric Oswald: Innovator in Gastrointestinal and Pain Disorder Treatments

Introduction

Eric Oswald is a notable inventor based in Toulouse, France. He has made significant contributions to the fields of gastrointestinal health and pain management through his innovative research and inventions. With a total of 4 patents, Oswald's work focuses on utilizing modified strains of bacteria to develop new therapeutic options.

Latest Patents

One of Oswald's latest patents is centered around a modified strain of Nissle 1917 (EcN) for the treatment of gastrointestinal disorders. This invention explores the mechanisms behind the probiotic properties of EcN, demonstrating how the ClbP protein can be modified to retain its beneficial effects while eliminating its genotoxic activity. This groundbreaking research paves the way for the safe use of EcN in treating gastrointestinal diseases.

Another significant patent involves the discovery of lipopeptide compounds with analgesic properties. These compounds, derived from the probiotic strain Nissle 1917, show promise in treating pain disorders, particularly visceral pain. The research highlights how these compounds can inhibit hypersensitivity and cross cellular barriers, offering new avenues for pain management.

Career Highlights

Throughout his career, Eric Oswald has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Toulouse University Hospital (Centre Hospitalier Universitaire De Toulouse). His work in these organizations has contributed to advancements in medical research and therapeutic development.

Collaborations

Oswald has collaborated with notable colleagues, including Patricia Martin and Nicolas Cenac. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Eric Oswald's contributions to the fields of gastrointestinal health and pain management through his innovative patents demonstrate his commitment to advancing medical science. His research not only opens new therapeutic possibilities but also highlights the importance of collaboration in the innovation process.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…